Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study-Reference-Cited by-同舟云学术

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Published:2021-07-08 Issue:8 Volume:44 Page:899-915
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Hoffman Veena^ORCID,Hallas Jesper^ORCID,Linder Marie^ORCID,Margulis Andrea V.^ORCID,Suehs Brandon T.^ORCID,Arana Alejandro^ORCID,Phiri Kelesitse^ORCID,Enger Cheryl^ORCID,Horter Libby^ORCID,Odsbu Ingvild^ORCID,Olesen Morten^ORCID,Perez-Gutthann Susana^ORCID,Xu Yihua,Kristiansen Nina Sahlertz^ORCID,Appenteng Kwame,de Vogel Stefan^ORCID,Seeger John D.^ORCID,Enger Cheryl,Seeger John,Hoffman Veena,Phiri Kelesitse,Hallas Jesper,Olesen Morten,Kristiansen Nina Sahlertz,Bahmanyar Shahram,Linder Marie,Kieler Helle,Odsbu Ingvild,Arana Alejandro,McQuay Lisa,Margulis Andrea,Perez-Gutthann Susana,Ziemiecki Ryan,Bunniran Su,Suehs Brandon,Uribe Claudia,Xu Yihua,Horter Libby,Appenteng Kwame,de Vogel Stefan,Robinson Noah Jamie,Xue Songlin,Wolfram Josie,Steup Achim,Giese-Pagac Jena,van Aarle Raymond,Sheth Neha,Burns David,Boone Natalie,Blauwet Mary Beth,D’Silva Milbhor,Franks Billy,Atsma Willem Jan,Auton Tim,Garbe Edeltraut,Ekbom Anders,Lee Todd,Weiss Noel,Rumsfeld John,Gao Sara Yuewen,Karslake Laura,Liu Nan,Reed Katherine,Turnbull Bruce,Yang Jing,Brooks Nicole,Mortimer Kathleen,

Funder

Astellas Pharma Inc.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-021-01095-7.pdf

Reference39 articles.

1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–8. https://doi.org/10.1111/j.1464-410X.2010.09993.x.

2. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77:1081–7. https://doi.org/10.1016/j.urology.2010.08.039.

3. Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32:230–7. https://doi.org/10.1002/nau.22295.